Mean intraoperative ETCO2 is a strong marker of oncologic outcomes in patients with PDAC after pancreaticoduodenectomy, with both extremes of the spectrum linked to a worse disease course. This observation has implications for patient selection and decision-making in cancer care.
Wetzel et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: